Reply to “Letter to the editor regarding ‘Stereotactic radiosurgery for bone metastases in oligometastatic prostate cancer patients: DESTROY-2 clinical trial subanalysis’”

• Francesco Deodato ^[2] ; Donato Pezzulla ^[1] ; Savino Cilla ^[1] ; Milena Ferro ^[1] ; Milly Buwenge ^[3] ; Alessio Giuseppe Morganti ^[3] ; Gabriella Macchia ^[1]
  1. [1] Catholic University of the Sacred Heart

     Catholic University of the Sacred Heart

     Milán, Italia

     
  2. [2] Radiation Oncology Unit, Gemelli Molise Hospital, Università Cattolica del Sacro Cuore, Largo A. Gemelli 1, 86100, Campobasso, Italy Istituto di Radiologia, Università Cattolica del Sacro Cuore, Rome, Italy
  3. [3] Radiation Oncology, IRCCS Azienda Ospedaliero, Universitaria di Bologna, Bologna, Italy Department of Experimental, Diagnostic, and Specialty Medicine-DIMES, Alma Mater Studiorum Bologna, University, Bologna, Italy

  Mostrar afiliaciones +
• Localización: Clinical & translational oncology, ISSN 1699-048X, Vol. 24, Nº. 6 (junio), 2022, págs. 1217-1218
• Idioma: inglés
• Enlaces
  • Texto completo (pdf)